Our management team combines the clinical expertise of heart specialists with the business acumen of professional healthcare managers. Our management team is supported by a medical advisory board of consultant cardiologists led by our group clinical director.
Our perspectives have been shaped by our healthcare sector experiences across a diverse range of blue-chip public, academic and industry sectors. These include front-line work in NHS, military and private hospitals, strategy consulting, corporate finance and the pharmaceutical & medical devices industry.
Alongside our senior managers, our company is supported by a large number (over 300) of specialist cardiac staff – doctors, nurses, radiographers and cardiac physiologists – these are the people that provide our services on a daily basis – delivering high-quality, cost-effective cardiac care through their excellent service ethos and uncompromising professionalism.
Dr Anil Ohri
Founder & Chief Executive
Anil is a doctor with 25 years of healthcare and business management experience spanning a career as a medical officer and surgeon in the British Army and NHS. He graduated from medical school in 1989 winning five undergraduate prizes. He then served with the Royal Army Medical Corps in the rank of Captain on operational tours in the Gulf War, Cyprus, Kenya and Nepal, before returning to the UK to work at the Queen Elizabeth Military Hospital in London and the Cambridge Military Hospital in Aldershot. He subsequently joined a surgical training rotation in Oxford and London and was awarded a surgical research scholarship from Yale University – he has published research papers in the areas of oncology and surgery. He left medicine to join the healthcare investment banking arm of Credit Suisse First Boston, before serving as Chief Executive of the European joint venture arm of MedCath Corporation – a multi-billion dollar cardiac services company with 11 specialist heart hospitals and 32 cardiology centres across the US.
Anil holds an MBA from London Business School (LBS) and founded Regent’s Park Healthcare in December 2002. He is the recipient of a number of personal business awards including the inaugural 2010 Accomplished Entrepreneur Award from LBS, and the 2011 Award for Entrepreneurial Achievement from the Independent Healthcare Industry. His companies have been finalists for UK HealthInvestor Awards across the categories of ‘Private Hospital group of the year’, ‘Diagnostic group of the year’ and ‘Healthcare Innovation of the year’. Anil has developed a broad range of expertise that enables him to bridge the complex communities of finance and healthcare. He is particularly expert in the areas of strategic planning and disruptive innovation. He is frequently invited to lecture at international meetings and advises a number of charity and industry organisations. He is a mentor on the highly successful Entrepreneurship Summer School and recently mentored the winning company at the 2018 LBS Healthtech Challenge – a business ideas competition helping young people to turn their health tech ideas into reality. Anil is shortly due to complete the Business Innovations in Global Healthcare Program at Harvard Business School. His company has been shortlisted as a Finalist in the ‘Public Private Partnership of the Year’ category at the 2018 UK HealthInvestor Awards. He has also just been shortlisted as a Finalist for Director of the Year Award 2018 by the Institute of Directors (London & South) in its Innovation Category.
Dr Dushan Gunasekera
Chief Financial Officer
Dush is a medical graduate of St. Bartholomew’s Hospital, London with a wealth of experience in the healthcare financial services sector. He left medicine to become a healthcare investment banker and has worked for the last fifteen years in a variety of leadership roles in Corporate Finance with Citigroup & Deloitte.
Citigroup is a US multinational financial services company with revenues exceeding $70 billon with 16,000 offices worldwide. Deloitte is one of the world’s top professional service firms providing audit, tax and corporate finance services.
Dush holds an MBBS degree from the University of London and MBA from the University of Oxford.
Mr Bryn Webber
Cardiac Services Director
Bryn is a cardiac nurse specialist with a focus on interventional cardiology. Bryn joined the company in 2004 and has spent his last ten years in both a clinical and managerial role, working in our cath labs, managing service operations and leading key areas of new venture development. Bryn is experienced in defining clinical business system requirements, designing and delivering innovative care solutions, as well as the implementation of consistent operational processes. He has a passion for creating high quality, patient-focused care pathways.
Bryn trained at the Wessex Cardiac Centre and holds a nursing qualification from Southampton University and PRINCE2® project management accreditation.
Dr Peter Schofield
Group Clinical Director
Dr Peter Schofield is currently a Consultant Cardiologist at Addenbrookes & Papworth Hospitals, Cambridge. He was appointed a Consultant Cardiologist in 1989 and is currently the Clinical Chairman of the Anglia Cardiac Network. The network is responsible for the strategic direction and provision of cardiac services within Cambridgeshire, Norfolk and Suffolk.
Peter’s subspecialty interest is in percutaneous coronary intervention procedures. His experience in this area covers some 25 years of practice. In recent years, he has carried out up to 750 procedures per year with a success rate of greater than 98%. He holds a Level 10 National Clinical Excellence Award. Peter has published over 150 research papers in peer-reviewed journals. He has also written 5 books on cardiovascular disease. His major research interest over the years has been the evaluation of new technologies in the cardiovascular field. Most of this work has been published in peer-reviewed journals. As a result of this, many techniques have now been incorporated into routine clinical practice.
Peter is a former Secretary of the British Cardiac Society and a Council Member of the British Cardiovascular Intervention Society. He is a Fellow of the Royal College of Physicians, Fellow of the American College of Cardiology and Fellow of the European Society of Cardiology.
Dr Thomas Burke
Chairman of Business Advisory Board
Tom is a non-executive Director and joined Regent’s Park in its founding year of 2002.
He is currently the President & Chief Executive Officer of Rowan Companies plc (Rowan).
Rowan is an oilfield services company listed on the New York Stock Exchange with revenues of $1 billion and a market capitalisation of around $4 billion. Tom previously worked for Mckinsey & Co., as a strategy consultant and at Schlumberger, an oil and gas conglomerate, where he held various positions across North America, China, Mongolia and Indonesia. Tom previously served in the British Army with the Parachute Regiment.
Tom has an MBA from Harvard Business School with high distinction (Baker Scholar) and holds a PhD in robotic engineering from the University of Oxford.
Dr Alistair Lindsay
Dr Alistair Lindsay is a consultant cardiologist at the Royal Brompton Hospital, London, UK. He joined Regent’s Park in 2013 to head-up its healthcare strategy division. He leads a team of strategy consultants that provide our NHS and industry clients with innovative solutions based on deep sector insight, analytical rigour, and an objective perspective.
Alistair joined the Royal Brompton in 2010 from Oxford where he was the John Radcliffe Hospital Cardiovascular Fellow. His main interest is the use of both invasive and non-invasive techniques to diagnose heart problems and to guide treatment. In particular, he has experience in the use of magnetic resonance imaging (MRI), computed tomography (CT), intravascular ultrasound (IVUS) and optical coherence tomography (OCT). He has published widely and participated in both local and international studies on the diagnosis and treatment of atherosclerosis. Dr Lindsay currently serves on the editorial board of the cardiovascular journal Heart, for which he serves as the digital media editor and contributes to the journal’s blog.
Alistair holds degrees in Molecular Biology and Medicine from the University of Edinburgh, a DPhil from the University of Oxford, and an MBA from London Business School. In 2010 he was named “Young Trainee of the Year” by the Royal Society of Medicine.
Mr Daniel Oberholzer
Business Advisory Board
Prior to joining the advisory board of Regent’s Park in 2012, Daniel worked as Director of Corporate Development at Regent’s Park from 2009. Before this, he held a variety of commercial and financial roles for HCA hospitals, the largest provider of private hospitals in London. He has also worked for a leading UK provider of diagnostic services with community based cardiac CT, MRI and nuclear imaging centres.
Daniel holds degrees in Commerce and Business Management from the University of Stellenbosch, South Africa.